α-Synuclein genetic variants predict faster motor symptom progression in idiopathic Parkinson disease
about
The prediagnostic phase of Parkinson's diseaseMitochondrial dysfunction and oxidative stress in Parkinson's diseasePredicting cognitive decline in Parkinson's disease: can we ask the genes?Circadian dysfunction may be a key component of the non-motor symptoms of Parkinson's disease: insights from a transgenic mouse modelThe association between ambient exposure to organophosphates and Parkinson's disease riskPACAP deficiency sensitizes nigrostriatal dopaminergic neurons to paraquat-induced damage and modulates central and peripheral inflammatory activation in miceNeurotoxicity of the Parkinson Disease-Associated Pesticide Ziram Is Synuclein-Dependent in Zebrafish EmbryosA Bayesian mathematical model of motor and cognitive outcomes in Parkinson's diseaseVariants in SNCA Gene Are Associated with Parkinson's Disease Risk and Cognitive Symptoms in a Brazilian Sample.Alpha-synuclein repeat variants and survival in Parkinson's diseaseSerum metabolomics of slow vs. rapid motor progression Parkinson's disease: a pilot study.Using gastrocnemius sEMG and plasma α-synuclein for the prediction of freezing of gait in Parkinson's disease patients.Head injury, α-synuclein genetic variability and Parkinson's disease.Variants in GBA, SNCA, and MAPT influence Parkinson disease risk, age at onset, and progression.Traumatic brain injury, paraquat exposure, and their relationship to Parkinson disease.Does α-synuclein have a dual and opposing effect in preclinical vs. clinical Parkinson's disease?Organophosphate Pesticide Exposures, Nitric Oxide Synthase Gene Variants, and Gene-Pesticide Interactions in a Case-Control Study of Parkinson's Disease, California (USA).Functional paraoxonase 1 variants modify the risk of Parkinson's disease due to organophosphate exposureLifetime occupational and leisure time physical activity and risk of Parkinson's disease.Pesticides that inhibit the ubiquitin-proteasome system: effect measure modification by genetic variation in SKP1 in Parkinson׳s disease.Job exposure matrix (JEM)-derived estimates of lifetime occupational pesticide exposure and the risk of Parkinson's disease.Aldehyde dehydrogenase variation enhances effect of pesticides associated with Parkinson disease.Common variant rs356182 near SNCA defines a Parkinson's disease endophenotypeSpecifically neuropathic Gaucher's mutations accelerate cognitive decline in Parkinson's.Pooled analysis of iron-related genes in Parkinson's disease: association with transferrin.The significance of GBA for Parkinson's disease.Genetic Variants in SNCA and the Risk of Sporadic Parkinson's Disease and Clinical Outcomes: A ReviewReview: Parkinson's disease: from synaptic loss to connectome dysfunction.Organophosphate pesticides and PON1 L55M in Parkinson's disease progression.A cumulative genetic risk score predicts progression in Parkinson's disease.SNCA Gene, but Not MAPT, Influences Onset Age of Parkinson's Disease in Chinese and Australians.APOE, MAPT, and COMT and Parkinson's Disease Susceptibility and Cognitive Symptom Progression.Mutations in PRKN and SNCA Genes Important for the Progress of Parkinson's Disease.SNCA rs356219 variant increases risk of sporadic Parkinson's disease in ethnic Chinese.Alpha-synuclein: one key opens many locks.The many faces of alpha-synuclein mutations.Social Cognition Impairments in Mice Overexpressing Alpha-Synuclein Under the Thy1 Promoter, a Model of Pre-manifest Parkinson's Disease.The PD-associated alpha-synuclein promoter Rep1 allele 2 shows diminished frequency in restless legs syndrome.Inventory of real world data sources in Parkinson's disease.Dopamine receptors and BDNF-haplotypes predict dyskinesia in Parkinson's disease.
P2860
Q26768732-65CA0E2E-3545-41C5-B57B-545C6DB5FD25Q27014051-FD5C99C8-D37D-4227-B850-5502E6717C79Q27025463-2BEE5369-0DF1-43F1-8BE0-803F93EE90F7Q28384426-3761E03B-F10E-440C-8BCA-C6D35775607EQ28389413-897BE9CB-8D37-431C-9F33-DAD1FEC9AC42Q28397422-BE98F9F7-05C3-457D-A2F3-B83979DD27B8Q29541727-2173C1A1-9F8E-4F81-AE7D-D889E478586DQ33788172-737E323E-FA0D-4A57-80C8-45504FBD15BBQ33813336-C49FE64B-B6E7-4842-8F0B-1CE3D58B29F3Q34231155-57CF7BEB-DCB5-4141-B502-A70B9BDEBA0AQ35027763-1999C05A-C5A2-4272-8DE8-63F972753FE0Q35107114-E6B611AA-9E3F-4644-8656-CC8F3D3DA3FCQ35327353-FA4DA61F-04F3-427A-9345-D34B98D2C512Q36395549-03E8CB53-06F3-4C84-B795-CD55437AB4F0Q36439181-AA693140-EBE5-44CF-90C6-B6480B53078AQ36491690-25BDDBB7-F7BE-4B69-864A-1B6FCD5C9433Q36874319-3E8CDDB5-A553-409D-9759-AC5380F67C73Q36948705-CE6460DF-9B0B-4C87-8CDA-49EBF7086CDBQ37022711-770355AA-80FF-4592-A5C3-FE815DA72276Q37320854-58E9BDA1-BB63-47DD-85D8-5A16E8C38FB8Q37565100-139FC76A-BAAE-4531-B359-473FC40ED5EEQ37567487-6F05E63A-2D2C-4E23-A179-C8D852C98942Q37572904-A1ECB7FA-9FF9-444D-9F96-FBDD4E0A43B2Q37593728-A8F9711D-2B23-49D4-B87D-4CAD0F411F65Q37671088-1E3F7887-7A40-4090-9E28-2244648B2A82Q38217376-1D31E753-77EC-4BD8-AB81-FE19B7823802Q38637878-20866AC6-7ACF-4A8C-AC89-34F2563BA077Q38650395-B74119EB-772B-453F-BAE4-1FC1D0D37E2DQ38660920-90E3A0E0-D2A2-4952-993F-F6D9D0814D36Q38725615-3DEB6525-7205-410D-A377-FB89E8CD88EDQ40047619-574479E3-D5C0-4595-84C7-3903EA17E55FQ40809659-9BF0F92E-B9EC-4D90-B76D-9298E11BAF2DQ41954719-B9C9B35C-2272-49DA-9491-5760B1284E0EQ43521013-E24E656B-D03E-42F8-9961-365FB5D0B22FQ45015107-43E52516-321E-4703-A7FF-AE068D0332E7Q45387129-F1C4BC40-98D8-452C-852C-EDD229D9A6CBQ46047010-0C0839D1-84C2-476E-A5DF-FDE45559D74FQ46962027-4DDEB6E4-B001-42BA-9BDB-15B255CB992EQ47101523-2F2AC5E8-0A75-4598-BA8E-B30D1F55492EQ47389217-D22F23AE-0DB2-4457-A591-B44C4CD9660B
P2860
α-Synuclein genetic variants predict faster motor symptom progression in idiopathic Parkinson disease
description
2012 nî lūn-bûn
@nan
2012 թուականին հրատարակուած գիտական յօդուած
@hyw
2012 թվականին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
α-Synuclein genetic variants p ...... n idiopathic Parkinson disease
@ast
α-Synuclein genetic variants p ...... n idiopathic Parkinson disease
@en
α-Synuclein genetic variants p ...... n idiopathic Parkinson disease
@en-gb
α-Synuclein genetic variants p ...... n idiopathic Parkinson disease
@nl
type
label
α-Synuclein genetic variants p ...... n idiopathic Parkinson disease
@ast
α-Synuclein genetic variants p ...... n idiopathic Parkinson disease
@en
α-Synuclein genetic variants p ...... n idiopathic Parkinson disease
@en-gb
α-Synuclein genetic variants p ...... n idiopathic Parkinson disease
@nl
altLabel
α-Synuclein Genetic Variants P ...... n Idiopathic Parkinson Disease
@en
prefLabel
α-Synuclein genetic variants p ...... n idiopathic Parkinson disease
@ast
α-Synuclein genetic variants p ...... n idiopathic Parkinson disease
@en
α-Synuclein genetic variants p ...... n idiopathic Parkinson disease
@en-gb
α-Synuclein genetic variants p ...... n idiopathic Parkinson disease
@nl
P2860
P921
P3181
P1433
P1476
α-Synuclein genetic variants p ...... n idiopathic Parkinson disease
@en
P2093
Jeff Bronstein
Shannon L Rhodes
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0036199
P407
P577
2012-01-01T00:00:00Z